Victoria is continuing to lead the way in mRNA manufacturing with the government agreeing to an in-principle partnership with ground-breaking German biotechnology company BioNTech.
The developers of the Pfizer/BioNTech Covid-19 mRNA vaccine have chosen Victoria to establish their Asia-Pacific mRNA clinical research and development centre which will form part of BioNTech’s global network. The new facility will support researchers to translate their work into medical breakthroughs.
Treasurer Tim Pallas and Minister for Innovation, Medical Research and the Digital Economy Jaala Pulford today announced an in-principle partnership with BioNTech to establish a clinical scale mRNA manufacturing facility in Melbourne, with Victoria and BioNTech entering formal discussions to bring this world leading company into the State, an official press release said.
The arrangement would see BioNTech deliver next-generation mRNA therapeutics and vaccines for research and clinical trials, including infectious diseases, cancer medicines and personalised cancer treatments.
It also includes BioNTech establishing its Artificial Intelligence-driven early warning and identification technology, which can be used to detect future disease threats and rapidly develop new treatments and vaccines, at the Victorian site.
Founded in 2008 in Germany, BioNTech has become a world leader in mRNA research and in 2020 successfully developed the Pfizer/BioNTech vaccine for COVID-19.
The in-principle partnership follows the Australian Government, Moderna and Victorian Government partnership to set up an mRNA vaccine manufacturing facility at Monash University – helping protect Australians against future pandemics, supporting local industry and creating highly skilled jobs.
Victoria is Australia’s leader in pharmaceutical and biological manufacturing, responsible for nearly 60 per cent of Australia’s pharmaceutical exports – making it our highest value advanced manufactured export.
The Labor Government has invested $1.3 billion in medical research since 2014 and has helped create more than 100,000 direct and indirect full-time jobs in the state’s biotech sector.
The Indian Sun acknowledges the support of the Victorian Government.
Support independent community journalism. Support The Indian Sun.
Follow The Indian Sun on Twitter | Instagram | Facebook
Victoria is continuing to lead the way in #mRNA manufacturing with the government agreeing to an in-principle partnership with ground-breaking German biotechnology company #BioNTech. #TheIndianSunhttps://t.co/2vNd2MFVxb
— The Indian Sun (@The_Indian_Sun) October 7, 2022
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
